Related references
Note: Only part of the references are listed.IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
T. Tiffany Wang et al.
LEUKEMIA (2019)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Th9 cells and IL-9 in autoimmune disorders: Pathogenesis and therapeutic potentials
Yaxiong Deng et al.
HUMAN IMMUNOLOGY (2017)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Targeting the Binding Interface on a Shared Receptor Subunit of a Cytokine Family Enables the Inhibition of Multiple Member Cytokines with Selectable Target Spectrum
Toshie Nata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
interleukin-2: Biology, Design and Application
Natalia Arenas-Ramirez et al.
TRENDS IN IMMUNOLOGY (2015)
Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD
Anne-Kathrin Hechinger et al.
BLOOD (2015)
IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction
Bana Jabri et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
Anjali Mishra et al.
CLINICAL CANCER RESEARCH (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
The Biology of IL-15: Implications for Cancer Therapy and the Treatment of Autoimmune Disorders
Thomas A. Waldmann
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2013)
Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα
Noriko Sato et al.
BLOOD (2011)
Neutralization of IL-9 Ameliorates Experimental Autoimmune Encephalomyelitis by Decreasing the Effector T Cell Population
Hongmei Li et al.
JOURNAL OF IMMUNOLOGY (2010)
Cellular sources and immune functions of interleukin-9
Randolph J. Noelle et al.
NATURE REVIEWS IMMUNOLOGY (2010)
IL-9 as a mediator of Th17-driven inflammatory disease
Elizabeth C. Nowak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Preclinical and phase I clinical trial of blockade of IL-15 using Mikβ1 monoclonal antibody in T cell large granular lymphocyte leukemia
JC Morris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients
T Nagato et al.
CLINICAL CANCER RESEARCH (2005)
Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells
CL Berger et al.
BLOOD (2005)
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease
B Meresse et al.
IMMUNITY (2004)
IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthma
A Shimbara et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Share Paper
